Difference between revisions of "Team:UCL/Safety"
Superjack15 (Talk | contribs) |
Superjack15 (Talk | contribs) |
||
Line 188: | Line 188: | ||
.content {color: #d67166;} | .content {color: #d67166;} | ||
− | .bigtitle { | + | .bigtitle {background-image:none/* url('https://static.igem.org/mediawiki/2015/4/43/UCL_headercircle.png')*/; text-align: center; line-height: 2; |
background-position: top center; background-repeat: no-repeat; background-size: contain; padding: 9%; position: relative; margin-bottom: 100px; color: #22343C;} | background-position: top center; background-repeat: no-repeat; background-size: contain; padding: 9%; position: relative; margin-bottom: 100px; color: #22343C;} | ||
Revision as of 20:34, 18 September 2015
'
B12 riboswitch
In order to address safety issues associated with our psychobiotics, we have developed a unique B12 riboswitch-mediated
containment strategy
▼